Interpreting Serological Tests in Diagnosing Autoimmune Liver Diseases
The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
Autoimmune liver diseases (ALD) are characterized by immune-mediated injury of bile ducts or hepatocytes, thus including cholangiopathies such as primary biliary cirrhosis (PBC), primary sclerosing cholangitis, and autoimmune hepatitis. Further, ALD variants manifesting with both hepatocellular and cholangiocellular damage are becoming more common. Serum autoantibodies, together with imaging and histology, are critical to the diagnostic process when ALD is suspected. Because an early diagnosis can influence prognosis, the development of sensitive and specific tests for serum autoantibodies should be a priority for researchers to ensure a more efficient noninvasive workup. Little prognostic value has been observed for any of the ALD serum hallmarks, and a vigorous effort to investigate new and old markers should therefore be undertaken in longitudinal studies as in the recent paradigm of PBC-specific antinuclear antibodies. We review herein the numerous ALD screening tests available in routine and specialized laboratories and comment on their significance in clinical practice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunofluorescent staining of nuclear dots (suggesting anti-sp100 reactivity) and perinuclear rims (suggesting anti-gp210 reactivity) are useful in the diagnosis of PBC in the 5-10% (depending on the assay) of patients with PBC who are AMA negative [37,[51][52][53][54].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [52]
In the citing paper
“AMA positivity is observed in more than 90% of patients with PBC [51]; immunofluorescence [1/40, or immunoenzymatic reactivity observed during cholestatic serum liver testing, is highly specific to the disease [52].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [52]
In the citing paper
“Immunofluorescent staining of nuclear dots (suggesting anti-sp100 reactivity) and perinuclear rims (suggesting anti-gp210 reactivity) are useful in the diagnosis of PBC in the 5-10% (depending on the assay) of patients with PBC who are AMA negative [37,[51][52][53][54].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [52]
In the citing paper
“immunofluorescence [1/40, or immunoenzymatic reactivity observed during cholestatic serum liver testing, is highly specific to the disease [52].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [52]
Citations
Cites
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis
Hamano, H., Kawa, S., Horiuchi, A., Unno, H., Furuya, N., Akamatsu, T., Fukushima, M., Nikaido, T., Nakayama, K., Usuda, N., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441005 · Cited by 2,705
Meeting report: International autoimmune hepatitis group
Johnson, P. J., & McFarlane, I. G. (1993) · Hepatology · doi:10.1002/hep.1840180435 · Cited by 1,090
Multiplexed particle-based flow cytometric assays
Vignali, D. A. A. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00238-6 · Cited by 913
Prognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816
(2015) · Diagnostic Imaging: Gastrointestinal · doi:10.1016/b978-0-323-37755-3.50202-6 · Cited by 811
Gregorio, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22131 · Cited by 692
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
Wies, I., Brunner, S., Henninger, J., Herkel, J., Kanzler, S., zum Büschenfelde, K.-H. M., & Lohse, A. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02166-8 · Cited by 636
Homberg, J.-C., Abuaf, N., Bernard, O., Islam, S., Alvarez, F., Khalil, S. H., Poupon, R., Darnis, F., Lévy, V.-G., Grippon, P., et al. (1987) · Hepatology · doi:10.1002/hep.1840070626 · Cited by 576
Lapierre, P., Hajoui, O., Homberg, J.-C., & Alvarez, F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70186-1 · Cited by 538
Cited by
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
“Immunological markers: The diagnostic hallmark of PBC is the presence of AMA, which are detected in serum of more than 90% of affected individuals; the specificity of AMA in PBC is greater than 95% [8].”
BackgroundHirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Self-citationCarbone, M., Sharp, S. J., Flack, S., Paximadas, D., Spiess, K., Adgey, C., Griffiths, L., Lim, R., Trembling, P., Williamson, K., et al. (2016) · Hepatology · doi:10.1002/hep.28017 · Cited by 354
“Consistent with other recent series,((7,18,19)) approximately 10% of participants had”
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Gulamhusein, A. F., & Hirschfield, G. M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0226-7 · Cited by 308
Autoimmune liver serology: Current diagnostic and clinical challenges
Bogdanos, D. P., Invernizzi, P., Mackay, I. R., & Vergani, D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3374 · Cited by 213
Self-citationAutoantibodies in primary sclerosing cholangitis
Hov, J. R., Boberg, K. M., & Karlsen, T. H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3781 · Cited by 187
Juran, B. D., Hirschfield, G. M., Invernizzi, P., Atkinson, E. J., Li, Y., Xie, G., Kosoy, R., Ransom, M., Sun, Y., Bianchi, I., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds359 · Cited by 150
“Despite the broad cellular expression of PDC-E2, the pathogenic immune inflammatory response in PBC appears to be targeted to the biliary epithelial cells (BECs) lining the small interlobular bile ducts.”
BackgroundInfluentialSelf-citationDrebber, U., Kasper, H., Ratering, J., Wedemeyer, I., Schirmacher, P., Dienes, H., & Odenthal, M. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01695.x · Cited by 140
Liu, H., Norman, G. L., Shums, Z., Worman, H. J., Krawitt, E. L., Bizzaro, N., Vergani, D., Bogdanos, D. P., Dalekos, G. N., Milkiewicz, P., et al. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.09.005 · Cited by 130
“Note that such a large proportion of AMA-negative patients reflects our case-finding strategy, not the expected prevalence of these cases in PBC population [3,4].”
BackgroundSelf-citationInfectome: A platform to trace infectious triggers of autoimmunity
Bogdanos, D. P., Smyk, D. S., Invernizzi, P., Rigopoulou, E. I., Blank, M., Pouria, S., & Shoenfeld, Y. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.12.005 · Cited by 109
Self-citationEtiopathogenesis of primary biliary cirrhosis
Lleo, A., Invernizzi, P., Mackay, I. R., Prince, H., Zhong, R.-Q., & Gershwin, M. E. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3328 · Cited by 94
Self-citationDisease-specific autoantibodies in primary biliary cirrhosis
Bogdanos, D. P., & Komorowski, L. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.12.019 · Cited by 107
Geoepidemiology of autoimmune liver diseases
Invernizzi, P. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.12.002 · Cited by 91
Self-citationManagement of cholestatic disease in 2017
de Vries, E., & Beuers, U. (2017) · Liver International · doi:10.1111/liv.13306 · Cited by 90
Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis
Reshetnyak, V. I. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7683 · Cited by 86
Liu, H., Liu, Y., Wang, L., Xu, D., Lin, B., Zhong, R., Gong, S., Podda, M., & Invernizzi, P. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-100 · Cited by 82
Self-citationFenoglio, D., Bernuzzi, F., Battaglia, F., Parodi, A., Kalli, F., Negrini, S., Palma, R. D., Invernizzi, P., & Filaci, G. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.05.004 · Cited by 85
Self-citationNew ELISA for Detecting Primary Biliary Cirrhosis–Specific Antimitochondrial Antibodies
Dähnrich, C., Pares, A., Caballeria, L., Rosemann, A., Schlumberger, W., Probst, C., Mytilinaiou, M., Bogdanos, D., Vergani, D., Stöcker, W., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118299 · Cited by 76
Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis
Bernuzzi, F., Fenoglio, D., Battaglia, F., Fravega, M., Gershwin, M. E., Indiveri, F., Ansari, A. A., Podda, M., Invernizzi, P., & Filaci, G. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.06.004 · Cited by 75
Self-citationGossard, A. A., & Talwalkar, J. A. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.09.002 · Cited by 78
The limitations and hidden gems of the epidemiology of primary biliary cirrhosis
Podda, M., Selmi, C. F., Lleò, A., Moroni, L., & Invernizzi, P. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.015 · Cited by 76
Self-citationUpdate on primary biliary cirrhosis
Invernizzi, P., Selmi, C., & Gershwin, M. E. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.02.014 · Cited by 69
Self-citationSun, C., Xiao, X., Yan, L., Sheng, L., Wang, Q., Jiang, P., Lian, M., Li, Y., Wei, Y., Zhang, J., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.01.005 · Cited by 66
Gatselis, N. K., Zachou, K., Norman, G. L., Gabeta, S., Papamichalis, P., Koukoulis, G. K., & Dalekos, G. N. (2013) · Autoimmunity · doi:10.3109/08916934.2013.801461 · Cited by 64
The pathogenesis, models and therapeutic advances of primary biliary cholangitis
Li, H., Guan, Y., Han, C., Zhang, Y., Liu, Q., Wei, W., & Ma, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111754 · Cited by 64
Vitamin D in autoimmune liver disease
Smyk, D. S., Orfanidou, T., Invernizzi, P., Bogdanos, D. P., & Lenzi, M. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.05.016 · Cited by 60
Self-citationLiver auto-immunology: The paradox of autoimmunity in a tolerogenic organ
Invernizzi, P. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.08.006 · Cited by 55
Self-citationPathway-based analysis of primary biliary cirrhosis genome-wide association studies
Kar, S. P., Seldin, M. F., Chen, W., Lu, E., Hirschfield, G. M., Invernizzi, P., Heathcote, J., Cusi, D., the Italian PBC Genetics Study Group, Almasio, P. L., et al. (2013) · Genes & Immunity · doi:10.1038/gene.2013.1 · Cited by 55
Self-citationEpstein-Barr Virus as a Trigger of Autoimmune Liver Diseases
Rigopoulou, E. I., Smyk, D. S., Matthews, C. E., Billinis, C., Burroughs, A. K., Lenzi, M., & Bogdanos, D. P. (2012) · Advances in Virology · doi:10.1155/2012/987471 · Cited by 57
Natural killer T (NKT) cells in autoimmune hepatitis
Mattner, J. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.09.008 · Cited by 53
MicroRNAs and extracellular vesicles in cholangiopathies
Olaizola, P., Lee, P. Y., Arbelaiz, A., Lapitz, A., Perugorria, M. J., Bujanda, L., & Bañales, J. M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.026 · Cited by 56
Zingaretti, C., Arigò, M., Cardaci, A., Moro, M., Crosti, M., Sinisi, A., Sugliano, E., Cheroni, C., Marabita, F., Nogarotto, R., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.018713 · Cited by 50
Self-citationde Graaf, K. L., Lapeyre, G., Guilhot, F., Ferlin, W., Curbishley, S. M., Carbone, M., Richardson, P., Moreea, S., McCune, C. A., Ryder, S. D., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1170 · Cited by 48
Self-citationNew insights into gastrointestinal and hepatic granulomatous disorders
Almadi, M. A., Aljebreen, A., Sanai, F. M., Marcus, V., Al-Meghaiseeb, E. S., & Ghosh, S. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.115 · Cited by 49
Obeticholic Acid for Primary Biliary Cholangitis
Floreani, A., Gabbia, D., & De Martin, S. (2022) · Biomedicines · doi:10.3390/biomedicines10102464 · Cited by 41
“As a consequence, many patients are asymptomatic, and most new diagnoses (up to 60%) are made after the discovery of increased serum biochemical markers of liver function during check-ups performed for unrelated purposes [4,5].”
BackgroundAutoimmune Hepatitis in a North American Aboriginal/First Nations Population
Minuk, G., Liu, S., Kaita, K. D. E., Wong, S., Renner, E. L., Rempel, J. D., & Uhanova, J. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/642432 · Cited by 37
Tracing environmental markers of autoimmunity: introducing the infectome
Bogdanos, D. P., Smyk, D. S., Invernizzi, P., Rigopoulou, E. I., Blank, M., Sakkas, L. I., Pouria, S., & Shoenfeld, Y. (2013) · Immunologic Research · doi:10.1007/s12026-013-8399-6 · Cited by 38
Self-citationTanaka, T., Zhang, W., Sun, Y., Shuai, Z., Chida, A. S., Kenny, T. P., Yang, G., Sanz, I., Ansari, A., Bowlus, C. L., et al. (2017) · Hepatology · doi:10.1002/hep.29245 · Cited by 35
Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis
Himoto, T., & Nishioka, M. (2013) · Autoimmunity Highlights · doi:10.1007/s13317-013-0046-7 · Cited by 37
Montali, L., Tanaka, A., Riva, P., Takahashi, H., Cocchi, C. A., Ueno, Y., Miglioretti, M., Takikawa, H., Vecchio, L. P., Frigerio, A., et al. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.004 · Cited by 29
Self-citationInvernizzi, P., Alessio, M. G., Smyk, D. S., Lleo, A., Sonzogni, A., Fabris, L., Candusso, M., Bogdanos, D. P., Iorio, R., & Torre, G. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-92 · Cited by 28
Self-citationMolecular diagnostics of primary biliary cirrhosis
Rigopoulou, E. I., & Dalekos, G. N. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.6.621 · Cited by 32
Pathophysiology of primary biliary cholangitis
Gulamhusein, A. F., & Hirschfield, G. M. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.05.012 · Cited by 35
Houri, I., & Hirschfield, G. M. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.06.006 · Cited by 33
Oliveira (2012) · Journal of Clinical Medicine Research · doi:10.4021/jocmr1060w · Cited by 25
Targeting Gut Microbiota for the Treatment of Primary Biliary Cholangitis: From Bench to Bedside
Zhang, L., Yang, L., & Chu, H. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00408 · Cited by 32
Denk, G., Omary, A., Reiter, F. P., Hohenester, S. D., Wimmer, R., Holdenrieder, S., & Rust, C. (2014) · Hepatology Research · doi:10.1111/hepr.12304 · Cited by 24
Alvaro, D., Carpino, G., Craxì, A., Floreani, A., Moschetta, A., & Invernizzi, P. (2020) · Liver International · doi:10.1111/liv.14627 · Cited by 25
Self-citationComprehensive review of autoantibodies in patients with hyper-IgM syndrome
Barbouche, M., Chen, Q., Carbone, M., Ben‐Mustapha, I., Shums, Z., Trifa, M., Malinverno, F., Bernuzzi, F., Zhang, H., Agrebi, N., et al. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.140 · Cited by 19
Self-citationLiaskos, C., Norman, G. L., Moulas, A. N., Garagounis, A., Goulis, I., Rigopoulou, E. I., & Dalekos, G. N. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.12.012 · Cited by 23
Beretta‐Piccoli, B. T., Guillod, C., Marsteller, I., Blum, R., Mazzucchelli, L., Mondino, C., Invernizzi, P., Gershwin, M. E., & Mainetti, C. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0448-0 · Cited by 20
Self-citationCy, Y., Leung, P. S. C., Yang, G.-X., Kenny, T. P., Zhang, W., Coppel, R. L., Norman, G. L., Ansari, A. A., Mackay, I. R., Worman, H. J., et al. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04577.x · Cited by 18
Novel strategies and therapeutic options for the management of primary biliary cholangitis
Khanna, A., & Jones, D. E. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17728669 · Cited by 16
Invernizzi, P., Bernuzzi, F., Lleò, A., Pozzoli, V., Bignotto, M., Zermiani, P., Crosignani, A. L., Battezzati, P. M., Zuin, M. G., Podda, M., et al. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.11.008 · Cited by 15
Self-citationFeuchtinger, M., Christ, S., Preuß, B. E., Dengjel, J., Duman, S., Stevanović, S., & Klein, R. (2009) · Gut · doi:10.1136/gut.2008.164335 · Cited by 15
Bombaci, M., Pesce, E., Torri, A., Carpi, D., Crosti, M., Lanzafame, M., Cordiglieri, C., Sinisi, A. M., Moro, M., Bernuzzi, F., et al. (2019) · Liver International · doi:10.1111/liv.14128 · Cited by 14
Self-citationClinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead
Chen, Y., Chen, R., Li, H., & Shuai, Z. (2025) · Immunologic Research · doi:10.1007/s12026-025-09622-9 · Cited by 14
Novel method for ANA quantitation using IIF imaging system
Peng, X.-D., Tang, J., Wu, Y., Yang, B., & Hu, J. (2013) · Journal of Immunological Methods · doi:10.1016/j.jim.2013.12.004 · Cited by 12
Genetic susceptibility to autoimmune liver disease
Mattner, J. (2011) · World Journal of Hepatology · doi:10.4254/wjh.v3.i1.1 · Cited by 13
Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22
Smyk, D. S., Mytilinaiou, M. G., Milkiewicz, P., Rigopoulou, E. I., Invernizzi, P., & Bogdanos, D. P. (2011) · Autoimmunity Highlights · doi:10.1007/s13317-011-0023-y · Cited by 10
Self-citationOral lichenoid lesions and serum antinuclear antibodies in T hai patients
Prucktrakul, C., Youngnak‐Piboonratanakit, P., Kanjanabuch, P., Prueksrisakul, T., & Thongprasom, K. (2014) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12257 · Cited by 10
Risk Stratification in Primary Biliary Cholangitis
Martini, F., Balducci, D., Mancinelli, M., Buzzanca, V., Fracchia, E., Tarantino, G., Benedetti, A., Marzioni, M., & Maroni, L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175713 · Cited by 14
Diagnosis and Treatment of Autoimmune Hepatitis
Lata, J. (2012) · Digestive Diseases · doi:10.1159/000336704 · Cited by 9
Markers of autoimmune liver diseases in postmenopausal women with osteoporosis
Demirdal, Ü. S., Çiftçi, İ. H., & Kavuncu, V. (2010) · Clinics · doi:10.1590/s1807-59322010001000008 · Cited by 9
Yang, H., Yang, H., Wang, L., Shi, H., Liu, B., Lin, X., Chang, Q., Chen, J. D. Z., & Duan, Z. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03036-w · Cited by 9
Preuß, B. E., Berg, C. P., Dengjel, J., Stevanović, S., & Klein, R. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02630.x · Cited by 8
Immune-mediated bile duct injury: The case of primary biliary cirrhosis
Selmi, C. F., Affronti, A., Ferrari, L., & Invernizzi, P. (2010) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v1.i4.118 · Cited by 7
Early Primary Biliary Cirrhosis: A New Association with Erythema Nodosum of Unknown Origin
Gatselis, N., Zachou, K., & Dalekos, G. Ν. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/121620 · Cited by 10
Care of the Cholestatic Patient
Gossard, A. A. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.11.005 · Cited by 11
Fetomaternal alloimmunity as a cause of liver disease
Smyk, D. S., Grammatikopoulos, T., Daponte, A. I., Rigopoulou, E. I., & Bogdanos, D. P. (2011) · Autoimmunity Highlights · doi:10.1007/s13317-011-0019-7 · Cited by 6
Alfano, A., Romito, A., Marchese, C. A., Battistini, M., Crotti, G., Ferrini, A., Mancinetti, C., Manetta, T., Mengozzi, G., Merlach, P., et al. (2016) · Immunologic Research · doi:10.1007/s12026-016-8838-2 · Cited by 7
Hepatobiliary Manifestations of Gastrointestinal and Nutritional Disorders
Samarasena, J., & Hu, K. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.09.003 · Cited by 5
Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis
Fejfar, T., Vaňásek, T., & Hůlek, P. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.084 · Cited by 5
Invernizzi, P., Leung, P. S. C., Ma, X., & Gershwin, M. E. (2013) · Springer eBooks · doi:10.1007/978-3-319-02096-9_18 · Cited by 5
Self-citationComplete spectrum of AMA-M2 positive liver disease in north India
Minz, R. W., Kaur, N., Anand, S., Aggarwal, R., Saikia, B., Das, A., & Chawla, Y. K. (2011) · Hepatology International · doi:10.1007/s12072-011-9326-3 · Cited by 5
Kerkar, N. N., & Mack, C. L. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139012102.021 · Cited by 3
Recent developments in the management of idiopathic cholestatic liver disease.
Imam, M. H., Weeding, E., & Lindor, K. D. (2012) · PubMed Central · Cited by 3
Mitra, S., & Minz, R. W. (2016) · International Journal of Surgical Pathology · doi:10.1177/1066896916657643 · Cited by 5
Autoimmune Hepatitis in Children
Kerkar, N. N., & Mack, C. L. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108918978.020 · Cited by 3
Chen, Y., Chen, S., Chuang, Y., & Chiang, B. (2023) · Clinical and Translational Discovery · doi:10.1002/ctd2.187 · Cited by 3
Primary Biliary Cirrhosis: Autoimmune Hepatitis Overlap Syndrome
Iezzoni, J. C. (2010) · Pathology Case Reviews · doi:10.1097/pcr.0b013e3181df4334 · Cited by 3
Multiple Autoimmune Propensity and B-Non-Hodgkin Lymphoma: Cause or Effect?
Koumati, E., Palassopoulou, M., Matsouka, P., Polyzos, A., Dalekos, G. Ν., & Zachou, K. (2011) · Autoimmune Diseases · doi:10.4061/2011/841325 · Cited by 2
Gossard, A. A. (2014) · Clinical gastroenterology · doi:10.1007/978-1-4939-1013-7_1 · Cited by 3
Orlien, S. M. S., Ahmed, T. A., Ismael, N. Y., Berhe, N. B., Lauritzen, T., Gundersen, S. G., & Johannessen, A. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/4980597 · Cited by 5
Amyotrophic Lateral Sclerosis and Primary Biliary Cirrhosis Overlap Syndrome: Two Cases Report
Zhang, H., Liu, Y., Li, Z., Liang, N., Zhou, X., Nie, X., Zhang, T., & Qi, W. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00890 · Cited by 4
Spengler, U. (2010) · Die Gastroenterologie · doi:10.1007/s11377-009-0390-3 · Cited by 2
Zamor, P. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-33628-8_10 · Cited by 2
Mastoraki, A. T. (2009) · Gastroenterology Research · doi:10.4021/gr2009.05.1295 · Cited by 1
Cristoferi, L., & Invernizzi, P. (2020) · Disease Markers · doi:10.1155/2020/2453908 · Cited by 1
Self-citationHepatic disorders in pregnancy
Hammoud, G. M., & Ibdah, J. A. (2021) · CRC Press eBooks · doi:10.1201/9781003222590-22 · Cited by 1
Dancygier, H. (2009) · Springer eBooks · doi:10.1007/978-3-540-93842-2_36 · Cited by 1
Autoimmune Lebererkrankungen und deren Überlappungssyndrome
Teufel, A., & Kanzler, S. (2015) · Die Gastroenterologie · doi:10.1007/s11377-014-0977-1
PREDICTION OF AUTOIMMUNEITY DISEASES: MITH, REALITY AND RISK
Ortega‐Hernandez, O., López-Guzmán, S., Rojas‐Villarraga, A., & Anaya, J. (2008) · Institutional Repository University of Antioquia (University of Antioquia)
Immune interactions with the liver
Karrar, A. (2008) · Figshare
Relationship between Autoimmunity and Cancer or Metabolic Abnormality in Liver Diseases
Himoto, T., Nishioka, M., & Masaki, T. (2014) · The Open Autoimmunity Journal · doi:10.2174/1876894601406010001
Zollner, G., & Trauner, M. (2014) · Wiener klinische Wochenschrift Education · doi:10.1007/s11812-014-0061-2
Managing the Patient with Features of Overlapping Autoimmune Liver Disease
Boberg, K. M. (2011) · Springer eBooks · doi:10.1007/978-1-60761-569-9_12
La cirrhose biliaire primitive : actualités
Corpechot, C. (2013)
Autoimmune Hepatitis and Overlap Syndromes
Yerian, L. M., & Hart, J. A. L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-443-06803-4.00029-0
Chinese Expert Consensus for the Diagnosis and Treatment of Cholestatic Liver Disease
Cheng, J. (2012) · Infection International/Infection International (Electronic Edition) · doi:10.1515/ii-2017-0019
Metadata
- Authors
- Invernizzi, P., Lleo, A., & Podda, M.
- Affiliations
- University of Milan (IT)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2007-05
- Volume
- 27
- Issue
- 2
- Pages
- 161-172
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2057559137
- Semantic Scholar
- 0a58fc9710d003122ddfa2675fd15232d706cbb4
- Cited by
- 107
- References
- 100
- Citations by year
- 2025: 5 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 2 · 2015: 3 · 2014: 7 · 2013: 13 · 2012: 12
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- autoimmune liver disease, serological tests, serum autoantibodies, primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune hepatitis, antinuclear antibodies, diagnostic biomarkers, non-invasive diagnosis, screening test
- MeSH terms
- Animals, Autoantibodies, Autoimmune Diseases, Humans, Liver Cirrhosis, Biliary, Mass Screening, Predictive Value of Tests, Sensitivity and Specificity, Cholangitis, Sclerosing, Biomarkers, Hepatitis, Autoimmune
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.